Investigation of probiotics in multiple sclerosisMultiple Sclerosis Journal, Volume 24, Issue 1, Page 58-63, January 2018. … read morePosted At: MS Journal
The efficacy of teriflunomide in patients who received prior disease-modifying treatments: Subgroup analyses of the teriflunomide phase 3 TEMSO and TOWER studies
The efficacy of teriflunomide in patients who received prior disease-modifying treatments: Subgroup analyses of the teriflunomide phase 3 TEMSO and TOWER studiesMultiple Sclerosis Journal, Ahead of Print. … read morePosted At: MS Journal
Unique gene therapy prevents, reverses multiple sclerosis in animal modelMultiple sclerosis can be inhibited or reversed using a novel gene therapy technique that stops the disease’s immune response in mouse models, researchers have found....
Immune-mediated encephalitis with daclizumab: The final nailMultiple Sclerosis Journal, Ahead of Print. … read morePosted At: MS Journal
Switching from branded to generic glatiramer acetate: 15-month GATE trial extension resultsMultiple Sclerosis Journal, Ahead of Print. … read morePosted At: MS Journal
- Next story Immune Therapy Reported to Reduce MRI-Detected MS Disease Activity in Relapsing MS in Two Small Stud
- Previous story Convergent effects of a functional C3 variant on brain atrophy, demyelination, and cognitive impairment in multiple sclerosis
Join Our Mailing List
- Retinal degeneration is associated with brain volume reduction and prognosis in radiologically isolated syndrome
- False hepatitis B and C viral serologies in patients with multiple sclerosis receiving high-dose biotin
- What to know about marijuana and multiple sclerosis
- Using graphene to detect ALS, other neurodegenerative diseasesPosted At: Science Daily
- Is the ketogenic diet good for multiple sclerosis?
- What is Lhermitte’s sign?
- What to know about multiple sclerosis and mood swings
- FDA Issues Warning About Rare Risk of Stroke and Artery Wall Tears with Use of Lemtrada Posted At: National MS Society
- Pregnancy and multiple sclerosis in the DMT era: A cohort study in Western Austria
- Fatigue at enrollment predicts EDSS worsening in the New York State Multiple Sclerosis Consortium